Growth Metrics

Tvardi Therapeutics (TVRD) Total Current Liabilities: 2013-2016

Historic Total Current Liabilities for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2016 value amounting to $11.5 million.

  • Tvardi Therapeutics' Total Current Liabilities rose 6.55% to $7.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $7.3 million, marking a year-over-year increase of 6.55%. This contributed to the annual value of $11.5 million for FY2016, which is 118.93% up from last year.
  • According to the latest figures from FY2016, Tvardi Therapeutics' Total Current Liabilities is $11.5 million, which was up 118.93% from $5.3 million recorded in FY2015.
  • Tvardi Therapeutics' Total Current Liabilities' 5-year high stood at $11.5 million during FY2016, with a 5-year trough of $3.4 million in FY2014.
  • In the last 3 years, Tvardi Therapeutics' Total Current Liabilities had a median value of $5.3 million in 2015 and averaged $6.7 million.
  • In the last 5 years, Tvardi Therapeutics' Total Current Liabilities plummeted by 37.46% in 2014 and then skyrocketed by 118.93% in 2016.
  • Yearly analysis of 4 years shows Tvardi Therapeutics' Total Current Liabilities stood at $5.4 million in 2013, then slumped by 37.46% to $3.4 million in 2014, then spiked by 55.03% to $5.3 million in 2015, then soared by 118.93% to $11.5 million in 2016.